Pullen Investment Management LLC Has $616,000 Stock Holdings in Humana Inc. (NYSE:HUM)

Pullen Investment Management LLC raised its holdings in shares of Humana Inc. (NYSE:HUM) by 3.1% in the 3rd quarter, HoldingsChannel reports. The firm owned 1,944 shares of the insurance provider’s stock after buying an additional 59 shares during the period. Pullen Investment Management LLC’s holdings in Humana were worth $616,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds have also added to or reduced their stakes in the company. Swedbank AB lifted its holdings in Humana by 3.0% during the 3rd quarter. Swedbank AB now owns 105,976 shares of the insurance provider’s stock valued at $33,567,000 after purchasing an additional 3,085 shares during the last quarter. Heritage Oak Wealth Advisors LLC acquired a new stake in shares of Humana during the second quarter worth $3,456,000. Mandatum Life Insurance Co Ltd lifted its holdings in shares of Humana by 115.4% during the third quarter. Mandatum Life Insurance Co Ltd now owns 14,000 shares of the insurance provider’s stock worth $4,434,000 after buying an additional 7,500 shares in the last quarter. APG Asset Management US Inc. lifted its holdings in shares of Humana by 3.0% during the second quarter. APG Asset Management US Inc. now owns 67,669 shares of the insurance provider’s stock worth $25,274,000 after buying an additional 1,955 shares in the last quarter. Finally, Sei Investments Co. lifted its holdings in shares of Humana by 0.4% during the first quarter. Sei Investments Co. now owns 61,897 shares of the insurance provider’s stock worth $21,462,000 after buying an additional 264 shares in the last quarter. Institutional investors and hedge funds own 92.38% of the company’s stock.

Humana Stock Performance

NYSE:HUM opened at $260.73 on Friday. The stock has a market cap of $31.39 billion, a P/E ratio of 18.60, a price-to-earnings-growth ratio of 2.04 and a beta of 0.50. The company has a current ratio of 1.66, a quick ratio of 1.66 and a debt-to-equity ratio of 0.70. The stock’s 50-day moving average is $306.51 and its 200-day moving average is $336.35. Humana Inc. has a 1-year low of $213.31 and a 1-year high of $527.18.

Humana (NYSE:HUM) last released its quarterly earnings results on Wednesday, July 31st. The insurance provider reported $6.96 earnings per share for the quarter, topping the consensus estimate of $5.89 by $1.07. The company had revenue of $29.54 billion for the quarter, compared to analysts’ expectations of $28.52 billion. Humana had a return on equity of 16.12% and a net margin of 1.53%. The business’s quarterly revenue was up 10.4% compared to the same quarter last year. During the same period in the previous year, the business posted $8.94 earnings per share. Equities research analysts anticipate that Humana Inc. will post 16.06 earnings per share for the current year.

Humana Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 31st. Investors of record on Tuesday, December 31st will be paid a $0.885 dividend. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.36%. The ex-dividend date of this dividend is Tuesday, December 31st. Humana’s dividend payout ratio is currently 25.25%.

Analyst Ratings Changes

A number of equities research analysts have recently weighed in on HUM shares. Truist Financial dropped their target price on Humana from $400.00 to $260.00 and set a “hold” rating for the company in a report on Friday, October 11th. Barclays dropped their target price on Humana from $364.00 to $250.00 and set an “equal weight” rating for the company in a report on Thursday, October 10th. Jefferies Financial Group downgraded Humana from a “buy” rating to a “hold” rating and dropped their target price for the stock from $519.00 to $253.00 in a report on Monday, October 7th. Bank of America downgraded Humana from a “neutral” rating to an “underperform” rating and dropped their target price for the stock from $376.00 to $247.00 in a report on Wednesday, October 2nd. Finally, Piper Sandler cut Humana from an “overweight” rating to a “neutral” rating and decreased their price target for the stock from $392.00 to $274.00 in a research report on Thursday, October 3rd. One analyst has rated the stock with a sell rating, nineteen have given a hold rating and six have issued a buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average price target of $315.33.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.